CD274 and neoplasm: Knocking down of PD-L1 in both tumors spontaneously resulted in tumor growth in their models, whereas therapeutic PD-L1 blockade augmented anti-tumor T cell responses and further extended survival, suggesting that PD-L1 expression by both the tumor and host plays distinct, partial roles in regulating anti-tumor immunity.